These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 7179129

  • 41. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K, Hoch S, Dima C, Varga J, Teodorescu M.
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [Abstract] [Full Text] [Related]

  • 42. [Titers of C 3 factor of serum complement in various autoimmune diseases].
    Lehman C, Andreis M, Bennett L, Godoy G.
    Rev Med Chil; 1972 Jan; 100(5):497-501. PubMed ID: 4625016
    [No Abstract] [Full Text] [Related]

  • 43. [Study of the secretion of 2,5 dihydroxyphenylpyruvic acid in collagen diseases].
    Hladíková D, Sobĕslavský C, Susta A, Havelka S.
    Fysiatr Revmatol Vestn; 1968 Jul; 46(4):201-9. PubMed ID: 5691511
    [No Abstract] [Full Text] [Related]

  • 44. [Pathology of the heart in collagen disease].
    Kawai S, Okada R.
    Ryumachi; 1984 Aug; 24(4):272-87. PubMed ID: 6151255
    [No Abstract] [Full Text] [Related]

  • 45. [Content of protein fractions, free amino acids and lipids in the exudate of the tympanic cavity in patients with otitis media].
    Preobrazhenskiĭ NA, Gamov VP, Gol'dman II.
    Vestn Otorinolaringol; 1973 Aug; 35(4):20-8. PubMed ID: 4787126
    [No Abstract] [Full Text] [Related]

  • 46. Systemic rheumatic disorders ("collagen disease") in childhood: lupus erythematosus, anaphylactoid purpura, dermatomyositis, and scleroderma. II.
    Hanson V, Kornreich H.
    Bull Rheum Dis; 1967 Feb; 17(6):441-6 concl. PubMed ID: 6040729
    [No Abstract] [Full Text] [Related]

  • 47. Elevated serum CA125 in progressive systemic sclerosis with pleural effusion.
    Kimura K, Ezoe K, Yokozeki H, Katayama I, Nishioka K.
    J Dermatol; 1995 Jan; 22(1):28-31. PubMed ID: 7897020
    [Abstract] [Full Text] [Related]

  • 48. [Contribution on the pathogenesis of ozena].
    Werner E.
    Z Laryngol Rhinol Otol; 1968 Mar; 47(3):217-22. PubMed ID: 5302685
    [No Abstract] [Full Text] [Related]

  • 49. [Clinical and pathological observations on collagen diseases].
    Tachibana T, Nishizaki O, Yamada H.
    Rinsho Byori; 1971 Aug; 19():Suppl:498. PubMed ID: 4400483
    [No Abstract] [Full Text] [Related]

  • 50. Circulating tumor necrosis factor alpha in rheumatoid arthritis.
    Borzì RM, Arfilli L, Focherini MC, Pulsatelli L, Meliconi R.
    Boll Soc Ital Biol Sper; 1993 Jan; 69(1):39-43. PubMed ID: 8329189
    [Abstract] [Full Text] [Related]

  • 51. [Protein changes in diffuse connective tissues diseases. Considerations on the mechanism of hypoalbuminemia].
    Cossermelli W, Netto MP, Carvalho N.
    Rev Hosp Clin Fac Med Sao Paulo; 1975 Jan; 30(2):120-5. PubMed ID: 1135557
    [No Abstract] [Full Text] [Related]

  • 52. [The content of free amino acids and protein fractions in the blood serum of patients with systemic scleroderma].
    Zhuk RD, Khrupina AIa.
    Vopr Revm; 1966 Jan; 6(3):40-2. PubMed ID: 5993388
    [No Abstract] [Full Text] [Related]

  • 53. [The binding capacity of serum immunoglobulins with amino acids in systemic lupus erythematosus].
    Zamulko AA, Fedorich VN, Amosova EN.
    Vrach Delo; 1991 Jul; (7):47-9. PubMed ID: 1771834
    [Abstract] [Full Text] [Related]

  • 54. [The clinical significance of study of autoimmune processes in systemic lupus erythematosus and various other collagenoses].
    Ivanova AV, Selivanova IA.
    Ter Arkh; 1968 Aug; 40(8):66-70. PubMed ID: 4393756
    [No Abstract] [Full Text] [Related]

  • 55. Serum concentrations of basic fibroblast growth factor in collagen diseases.
    Kadono T, Kikuchi K, Kubo M, Fujimoto M, Tamaki K.
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):392-7. PubMed ID: 8784275
    [Abstract] [Full Text] [Related]

  • 56. [The level of serum thymic activity in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Ternovoĭ KS, Selezneva TN, Gandzha IM, Babynina LIa, Skorik AIu, Ermekova VM.
    Ter Arkh; 1993 Sep; 65(8):66-7. PubMed ID: 8211807
    [Abstract] [Full Text] [Related]

  • 57. [The differential diagnostic significance of the binding capacity of serum immunoglobulins with amino acids in rheumatism, rheumatoid arthritis and systemic lupus erythematosus with a minimal degree of activity].
    Amosova EN, Fedorich VN, Zamulko AA.
    Lik Sprava; 1994 Feb; (2):20-3. PubMed ID: 8073710
    [Abstract] [Full Text] [Related]

  • 58. [Dermatologic aspects of collagen disease (author's transl)].
    Quiñones PA.
    An Esp Pediatr; 1981 Jul; 15(1):63-8. PubMed ID: 7316292
    [Abstract] [Full Text] [Related]

  • 59. [Regional blood circulation in various collagen diseases].
    Bagirova VV, Bagirova GG.
    Ter Arkh; 1981 Jul; 53(8):101-5. PubMed ID: 7292327
    [No Abstract] [Full Text] [Related]

  • 60. Systemic rheumatic disorders ("collagen disease") in childhood: lupus erythematosus, anaphylactoid purpura, dermatomyositis, and scleroderma. I.
    Hanson V, Kornreich H.
    Bull Rheum Dis; 1967 Jan; 17(5):435-40 contd. PubMed ID: 6044284
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.